Clinica's Indian Market Briefing

Summary

What's going on in the Indian medtech markets? You can get the full picture with Clinica's Indian Market Briefing.
International healthcare companies are eyeing India, with its improving economic conditions, population of one billion and counting and a flourishing private sector of hospitals, as a major trading destination. Can you afford to sit on the sidelines and miss out on the massive commercial opportunities that this emerging market presents?
Clinica's Indian Market Briefing is the new addition to the Clinica Reports portfolio, and aims to provide clarity on key questions about the Indian medical diagnostics and devices market for companies wanting to do business in the region.

This report will help you to:

- Evaluate the size of the Indian healthcare and medtech markets and get a snapshot of the economic and political conditions
- Identify growth sectors and emerging trends
- Monitor your competitors' activities in the Indian market and learn from their experiences
- Be aware of potential commercial barriers

Areas covered include:

- How stable is the Indian political scenario and how are the healthcare system and products market affected?
- What is driving the medtech market and what sectors are thriving or emerging?
- How strong is IPR in the Indian market and what can be done to safeguard it?
- What gives a company the competitive edge in the Indian market?
- What regulations are in place for medical technologies and what are the procedures?
- What subsidies or tax incentives does the Indian government provide for medtech products?
- What are the long-term needs of the market that Indian industry leaders are targeting and developing strategies for?

Contents

• Chapter 1 Economic overview
  • 1.1 Introduction
  • 1.2 Domestic environment
  • 1.3 Economic outlook
  • 1.4 OTher initiatives
• Chapter 2 Healthcare system
  • 2.1 Introduction
  • 2.2 Insurance
  • 2.3 Declining public sector spending
  • 2.4 The rural-urban imbalance
    • 2.4.1 An ideal scenario
  • 2.5 Accreditation
  • 2.6 Concerns around diagnostic service providers
  • 2.7 Equipment usage
  • 2.8 The Clinical Establishment Act
  • 2.9 Medical visas
  • 2.10 Foreign Direct Investment (FDI)
  • 2.11 Regulation of medical devices
  • 2.12 Public-Private Partnerships (PPPs)
  • 2.13 Infrastructure development
  • 2.14 Demographic and epidemiological trends
• Chapter 3 Doing business
  • 3.1 Introduction
  • 3.2 The nature of The market
  • 3.3 Intellectual property (IP)
  • 3.4 Bureaucracy
  • 3.5 Entering The market
    • 3.5.1 Procurement issues
    • 3.5.2 Special Economic Zones (SEZs)
    • 3.5.3 Business centres
    • 3.5.4 Public-private partnerships (PPPs)
  • 3.6 Import information
  • 3.7 Culture
  • 3.8 Travel
  • 3.9 Business challenges
  • 3.10 Key advice
• Chapter 4 The medical device market
  • 4.1 Introduction
  • 4.2 Market size, growth and forecasts
  • 4.3 Indian manufacturing
  • 4.2 Epidemiological data
    • 4.2.1 Lifestyle and infectious diseases
  • 4.3 Regulation
    • 4.3.1 Medical devices
      • 4.3.1.1 Import
      • 4.3.1.2 Manufacture
      • 4.3.1.3 Sale
      • 4.3.1.4 Industry reactions and suggestions
  • 4.4 New regulatory areas
    • 4.4.1 Blood banks, medical imaging
    • 4.4.2 Stem Cells
    • 4.4.3 Clinical trials
    • 4.4.4 Diagnostic kits and reagents
• Chapter 5 Medical device sectors
  • 5.1 Hospitals
    • 5.1.1 International Partnerships
    • 5.1.2 Leading corporate hospitals
      • 5.1.2.1 OTher key hospitals
  • 5.2 The rural sector
  • 5.2 Telemedicine (distant monitoring and treatment of patients)
    • 5.2.1 Leading providers of telemedicine services
  • 5.3 Preventive healthcare and in vitro diagnostics
    • 5.3.1 In vitro diagnostics
      • 5.3.1.1 Market characteristics
      • 5.3.1.2 Needs and trends
      • 5.3.1.3 Methods
      • 5.3.1.4 Market drivers
    • 5.3.2 Segment data
      • 5.3.2.1 Biochemistry equipment and reagents
      • 5.3.2.2 Haematology equipment and reagents
      • 5.3.2.3 Immunoassay equipment and reagents
      • 5.3.2.4 Microbiology, molecular biology and oThers
      • 5.3.2.5 Molecular diagnostics market
      • 5.3.2.6 Biochemistry
    • 5.3.3 Challenges facing India's IVD sector
  • 5.4 Medical Tourism
• Chapter 6 Companies and opinion leaders
  • 6.1 Medical technology companies in India
    • 6.1.1 Indian companies
      • 6.1.1.1 Sahajanand Medical Technologies
      • 6.1.1.2 Wipro Biomed
        • www.wiprobiomed.in
        • Products
      • 6.1.1.3 Wipro Technologies and GE Healthcare
      • 6.1.1.4 Blue Star India
        • Products
      • 6.1.1.5 Trivitron
      • 6.1.1.6 BPL
      • 6.1.1.7 Angiplast
      • 6.1.1.8 Hindustan Syringes & Medical Devices
      • 6.1.1.9 RAC Exports
      • 6.1.1.10 J Mitra & Co
    • 6.1.2 International companies
      • 6.1.2.1 Johnson & Johnson
      • 6.1.2.2 Philips Medical Systems India
      • 6.1.2.3 Siemens Medical Solutions Ltd
      • 6.1.2.4 Hitachi India Pvt Ltd
      • 6.1.2.5 Boston Scientific Corporation
      • 6.1.2.6 Roche Diagnostics India Ltd
      • 6.1.2.7 Larsen & Toubro Medical Equipment
      • 6.1.2.8 Becton Dickinson India
      • 6.1.2.9 3M Health Care
      • 6.1.2.10 Ansell
  • 6.2 Diagnostics companies in India
    • 6.2.1 Indian diagnostics companies
      • 6.2.1.1 Span Diagnostics
        • Products
    • 6.2.2 OTher prominent Indian diagnostics companies
    • 6.2.3 International diagnostics companies in India
  • 6.3 Laboratories
  • 6.4 Leading industry figures
    • 6.4.1 Dr Govindappa Venkataswamy
    • 6.4.2 Dr Devi Shetty
    • 6.4.3 Dr Naresh Trehan
    • 6.4.4 Dr Raghunath Mashelkar
    • 6.4.5 Dr Abdul Kalam, President of India
    • 6.4.6 Kapil Sibal, minister of science and technology
• List of Tables:
  • Table 1.1 General economic data
  • Table 2.1 Compared growth of public & private expenditures
  • Table 2.2 Life expectancy and healthcare spending
  • Table 2.3 Rural-urban funding disparities 2002/2003 (Rs million, per capita)
  • Table 2.4 Estimate of required providers and facilities
  • Table 2.5 A selected epidemiological profile
  • Table 2.6 Population distribution according to age
  • Table 3.1 History of The Special Economic Zones
  • Table 3.2 Cultural catchwords, notes and advice
  • Table 4.1 Medical equipment imports and exports
  • Table 4.2 Selected exports to India: Volume (top line figs)/Value (lower line figs) (Rupees
    • million) 1991-2003
• Table 4.3 Projected deaths by cause, all ages, India 2005
  • Table 4.4 Infectious diseases profile
  • Table 4.5 Diagnostics value and growth statistics
  • Table 4.6 Selected information about oTher prevalent health conditions:
  • Table 5.1 Healthcare infrastructure